Fibroblast growth factor 2 (FGF2) is a mitogen that induces proliferation, differentiation, and migration of cells, as well as angiogenesis and carcinogenesis via autocrine or paracrine actions. Fibroblast growth factor 2 expression is abundant in porcine conceptuses and endometrium during the estrous cycle and peri-implantation period of pregnancy. However, its intracellular actions in uterine epithelial cells have not been reported. The results of this study indicated abundant expression of FGFR1 and FGFR2 predominantly in uterine luminal and glandular epithelia during early pregnancy and that their expression decreased with increasing parity of the sows. Treatment of porcine uterine luminal epithelial (pLE) cells with FGF2 increased proliferation and DNA replication based on increases in proliferating cell nuclear antigen (PCNA) and initiation of G 1 /S phase progression. In addition, FGF2 increases phosphorylation of AKT, P70S6K, S6, ERK1/2, JNK, P38, and P90RSK in a time-dependent manner, and increases in their expression was suppressed by Wortmannin (a phosphatidylinositol 3-kinase [PI3K] inhibitor), U0126 (an ERK1/2 inhibitor), SP600125 (a JNK inhibitor), and SB203580 (a P38 inhibitor) based on western blot analyses. Also, the abundance of cytoplasmic p-AKT protein was decreased by Wortmannin and U0126, and p-ERK1/2 protein was reduced only by U0126. Furthermore, inhibition of each signal transduction protein reduced the ability of FGF2 to stimulate proliferation and migration of pLE cells. Collectively, these results indicate that activation of FGFR1 and FGFR2 by uterine-and endometrial-derived FGF2 stimulates PI3K/AKT and mitogen-activated protein kinase pathways for development of the porcine uterus and improvement of litter size.
Introduction
For successful establishment and maintenance of uterine receptivity in pigs, reciprocal communication between conceptuses and uterine luminal (LE) and glandular epithelia (GE) is regulated by endocrine, autocrine, and paracrine signaling to enhance implantation and placentation [1] . Pig embryos enter the uterus on approximately day 4 of pregnancy and develop to spherical, tubular, and filamentous conceptuses (embryo and its extraembryonic membranes). Coincidentally, the endometrium undergoes considerable morphological changes in response to the elongating blastocysts in terms of length of uterine horns and proliferation of endometrial cells, as well as secretion and/or transport of molecules that constitute uterine histotroph. Uterine histotroph includes estrogens, interferons (IFN), prostaglandins, growth factors, and cytokines required for uterine receptivity to implantation of conceptuses beginning on day 13 of pregnancy [2, 3] . For example, conceptus-secreted estrogens induce expression of genes that regulate endometrial remodeling for successful implantation in pigs [4] . In addition, paracrine actions are mediated by IFN, both type I (IFN-δ) and type II (IFN-γ ), from trophectoderm that activates IFN-stimulated genes uterine GE and stromal cells, but not uterine LE that affects uterine receptivity to implantation and placentation [5] . Moreover, abundant expressions of growth factors including epidermal growth factor (EGF) [6] , insulinlike growth factor (IGF) [7] , and vascular endothelial growth factor (VEGF) [8] play important roles during the peri-implantation period of pregnancy and are associated with proliferative and migratory properties of cells of the porcine conceptus.
Fibroblast growth factor (FGF) family members exert various effects on cellular processes including stimulation of proliferation, differentiation, and migration of cells via autocrine or paracrine cell signaling [9] . Fibroblast growth factor 2 (also known as basic FGF) plays important role(s) in embryogenesis, tissue regeneration, and metabolisms and is widely distributed in adult and fetal tissues such as uterus, cornea, and vascular endothelial cells [10] [11] [12] . In particular, endometrial-derived FGF2 enhances ovine placental development by regulating angiogenesis [13] , trophectoderm outgrowth in mice [14] , and endometrial receptivity in women [15] . In addition, FGF2 has been reported to stimulate secretion of interferon-tau (IFNT) that is a novel early pregnancy recognition signal secreted by trophectoderm cells in ruminants. Also, FGF2 mRNA is expressed by endometrial epithelia and stromal cells, and conceptus trophectoderm of pigs during pregnancy [16] . Fibroblast growth factor 2 binds four transmembrane tyrosine kinase receptors (FGFR1-FGFR4) that consist of three extracellular immunoglobulin (Ig I-Ig III) domains with different affinities [17] to elicit its biological effects. Among these domains, the Ig II and Ig III form a distinct ligand-binding site for FGF family members, whereas the Ig I domain is regarded as an autoinhibitory regulator in modulating FGFR-mediated cell signaling [18] . For ligand-binding specificities, alternative splicing in the Ig III domain of FGFR1, FGFR2, and FGFR3 generates exons IIIb and IIIc that encode for the transmembrane region [19] . For intracellular signaling, FGF2 commonly binds with high affinity to FGFR1IIIc and FGFR2IIIc and dimerization of each of those receptor induces transphosphorylation of tyrosine kinase domains and intracellular signaling substrates leading to proliferation, differentiation, and migration of cells [20] . In the porcine endometrium, FGFR1 and FGFR2 are expressed in the endometrium during the estrous cycle (day 12 and 20) and pregnancy (day 1 and 12) [21] . Even though administration of recombinant FGF2 stimulates proliferation and differentiation of uterine luminal epithelial cells, little is known about interactions between FGF2 and its receptors in the porcine uterus to regulate implantation.
Therefore, the objectives of this study were to: (1) determine cellspecific expression of FGFR1 and FGFR2 mRNAs in the porcine endometrium during the estrous cycle and early pregnancy; (2) determine the effects of parity of sows on expression of FGFR1 and FGFR2 mRNAs in the endometrium on day 28 of pregnancy; (3) demonstrate regulatory effects of FGF2 on proliferation and cell cycle of porcine uterine luminal epithelial (pLE) cells; and (4) identify intracellular signaling mechanisms induced by FGF2 that lead to proliferation and migration of pLE cells. Results of this study provide novel insights into the FGF2-induced uterine receptivity through proliferation of pLE cells activation of the phosphatidylinositol 3-kinase (PI3K)/AKT and mitogen-activated protein kinase (MAPK) signal transduction pathways in early pregnancy.
Materials and methods

Experimental animals and animal care
Sexually mature gilts of similar age, weight, and genetic background were observed daily for estrus (day 0) and exhibited at least two estrous cycles of normal duration (18-21 days) before being used in this study. All experimental and surgical procedures were in compliance with the Guide for Care and Use of Agricultural Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Texas A&M University.
Experimental design and tissue collection
Gilts were assigned randomly to either cyclic or pregnant status. Those in the pregnant group were bred when detected in estrus and 12 and 24 h later. Gilts were ovariohysterectomized on either day 9, 12, or 15 of the estrous cycle or on day 9, 10, 12, 13, 14, 15, 20, or 30 of pregnancy (n = 3-4 pigs per day per status). For confirmation of pregnancy prior to implantation, the lumen of each uterine horn was flushed with 20 mL of physiological saline and examined for the presence of morphologically normal conceptuses. Uteri from cyclic and pregnant gilts were processed to obtain several sections (∼0.5 cm) from the entire uterine wall in the middle of each uterine horn, the tissue was fixed in fresh 4% paraformaldehyde in phosphate buffer saline (PBS) (pH 7.2), and the tissue was processed and embedded in Paraplast-Plus (Leica, Wetzlar, Germany).
Cell culture
A spontaneously immortalized pLE cell line [22] was cultured and used in the present in vitro studies. This cell line was developed by immortalizing primary uterine LE cells by transfection with the replication-defective retrovirus (SV40) vector pLXSN-16E6E7 expressing E6/E7 proteins of human papilloma virus type 16 [22] . The pLE cells have typical epithelial-like cobblestone-shaped morphology, and show positive staining with antibodies to epitheliumspecific cytokeratin and negative staining for vimentin [22] . The pLE forms a single monolayer at confluence. All analyses of protein expression and cell migration were performed on pLE cells between passages 25 and 30. Briefly, monolayer cultures of pLE cells were grown in DME/F12 1:1 culture medium containing 20% fetal bovine serum to 80% confluence in 100-mm tissue culture dishes. For assays, in vitro cultured pLE cells were serum starved for 24 h, and then incubated in the presence of various treatments.
RNA isolation
Total cellular RNA was isolated from endometrium of cyclic and pregnant gilts using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and purified using an RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. The quantity and quality of total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Quantitative polymerase chain reaction analysis
Specific primers for porcine FGFR1 (forward: 5 -GCG ACA CCA CCT ACT TCT CC-3 ; reverse: 5 -CTC TGG GGA TGT CCA GTA CG-3 ) and FGFR2 (forward: 5 -TCG CAT TGG AGG CTA TAA GG-3 ; reverse: 5 -GAT TGA TGG ACC CGT AAT CG-3 ) were designed from sequences in the GenBank database using Primer 3 (ver. 4.0.0). All primers were synthesized by Bioneer (Daejeon, Republic of Korea). Gene expression levels were measured using SYBR Green (Sigma, St. Louis, MO, USA) and a StepOnePlus Real-Time PCR System (Applied Biosystems, Waltham, MA, USA). The polymerase chain reaction (PCR) conditions were 95
• C for 3 min, followed by 40 cycles at 95
• C for 20 s, 64
• C for 40 s, and 72
• C for 1 min using a melting curve program (increasing the temperature from 55
• C to
95
• C at 0.5
• C per 10 s) and continuous fluorescence measurements.
Sequence-specific products were identified by generating a melting curve in which the C T value represented the cycle number at which a fluorescent signal was significantly greater than background, and relative gene expression was quantified using the 2 -CT method.
The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as the endogenous control to standardize the amount of RNA in each reaction.
Cloning of partial complementary DNA for porcine FGFR1 and FGFR2
Complementary DNA (cDNA) was synthesized using AccuPower RT PreMix (Bioneer Inc.). Partial cDNAs for porcine FGFR1 and FGFR2 mRNAs were amplified using specific primers based on data for porcine FGFR1 (GenBank accession no. XM 001928696: forward, 5 -GAC ATC CCC AGA GAA GAT GG-3 ; reverse, 5 -GCA CAT GAA TTC CAC ATT GC-3 ) and porcine FGFR2 (GenBank accession no. NM 001099924.2: forward, 5 -ATG CTT GTA CCG CTG CTA GG-3 ; reverse, 5 -GAT TGA TGG ACC CGT AAT CG-3 ). The partial cDNAs for FGFR1 and FGFR2 were gel extracted and cloned into the TOPO TA cloning vector (Invitrogen).
In situ hybridization analysis
After verification of the sequences, the plasmids containing gene sequences were amplified with T7-and SP6-specific primers (T7: 5 -TGT AAT ACG ACT CAC TAT AGG G-3 ; SP6: 5 -CTA TTT AGG TGA CAC TAT AGA AT-3 ), and then digoxigenin (DIG)-labeled RNA probes were transcribed using a DIG RNA labeling kit (Roche, Indianapolis, IN, USA). The tissue sections were deparaffinized, rehydrated, and treated with 1% Triton X-100 in PBS for 20 min and washed two times in DEPC-treated PBS. After postfixation in 4% paraformaldehyde, sections were incubated in a prehybridization mixture containing 50% formamide and 4× standard saline citrate for at least 10 min at room temperature. After hybridization and blocking steps, the sections were incubated overnight with sheep anti-DIG antibody conjugated to alkaline phosphatase (Roche). The signal was visualized by exposure to a solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma-Aldrich).
Reagents
The 
Proliferation assay
Proliferation assays were conducted using Cell Proliferation ELISA, BrdU kit (Cat No. 11647229001, Roche) according to the manufacturer's recommendations. Briefly, the pLE cells were seeded in a 96-well plate, and then incubated for 24 h in serum-free DME/F12 1:1 medium. Cells were then treated with FGF2 alone or with various inhibitors of cell signaling in a final volume of 100 μL/well. After 48 h of incubation, 10 μM BrdU was added to the cell culture and the cells were incubated for an additional 2 h at 37
Migration assay
Cell migration was evaluated using Ibidi migration culture dish inserts according to the manufacturer's protocol (Ibidi, Munich, Germany). A 70-μL suspension of pLE cells (2 × 10 5 cells/mL) was seeded into each well of the culture inserts and grown overnight to full confluence. After cell starvation for 24 h, the culture inserts were removed from the surface, and a 500-μm width cell-free gap between two defined cell patches was created. Cells were incubated with different treatments in fresh culture medium to start the migration process. The migration of cells into the defined cell-free gap (500 μm) was observed, and light microscopy images of the gap fields were acquired after 20 h using a light microscope DM3000 (Leica). For analyses of migration of pLE cells, we used the gap closure method in which migration was estimated using Leica Application Suite software.
Cell cycle analysis
Cells were seeded in a 6-well plate, and then incubated for 24 h in serum-free DME/F12 1:1 medium. Cells were then treated with FGF2 in a dose-dependent manner (0, 5, 10, 20, 50, and 100 ng) for 48 h. After treatment, the cells were centrifuged, washed two times with cold 0.1% bovine serum albumin (BSA) in PBS, and fixed in 70% ethanol at 4
• C for 24 h. The pLE cells were then centrifuged and the supernatant was discarded. Pellets were washed two times with 0.1% BSA in PBS and stained with propidium iodide (PI; BD Biosciences, Franklin Lakes, NJ, USA) in 100 μg/mL RNase A (Sigma-Aldrich) for 30 min in the dark. Fluorescence intensity was analyzed using a flow cytometer (BD Biosciences).
Immunofluorescence analysis
The effects of FGF2 on the expression of PCNA, Cyclin D1, p-AKT, and p-ERK1/2 were determined by immunofluorescence microscopy. The pLE cells (3 × 10 4 cells per 300 μL) were seeded on confocal dishes (catalog number: 100350, SPL Life Science, Republic of Korea), and then incubated for 24 h in serum-free DME/F12 1:1 medium. For the PCNA and Cyclin D1 protein, the serum-starved cells were treated with FGF2 for 24 h, while pretreated with pharmacological inhibitors for 2 h, and then the cells were treated with FGF2 for 30 min for p-AKT and p-ERK1/2 staining. The cells were fixed using methanol and probed with mouse antihuman monoclonal PCNA and rabbit antihuman polyclonal Cyclin D1 at a final dilution of 1:100, and rabbit antihuman polyclonal p-AKT and p-ERK1/2 MAPK at a final dilution of 1:200. Negative controls for background staining included substitution of the primary antibody with purified nonimmune mouse IgG or rabbit IgG. Cells were then incubated with goat antimouse IgG Alexa 488 (catalog number: A11017, Invitrogen) or goat antirabbit IgG Alexa 488 (catalog number: A-11008, Invitrogen) at a 1:200 dilution for 1 h at room temperature. Then, pLE cells were washed using 0.1% BSA in PBS and overlaid with 4 ,6-diamidino-2-phenylindole (DAPI). For each primary antibody, images were captured using a LSM710 (Carl Zeiss, Thornwood, NY, USA) confocal microscope.
Western blot analyses
Concentrations of protein in whole-cell extracts were determined using the Bradford protein assay (Bio-Rad, Hercules, CA, USA) with BSA as the standard. Proteins were denatured, separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose. Blots were developed using enhanced chemiluminescence detection (SuperSignal West Pico, Pierce, Rockford, IL, USA) and quantified by measuring the intensity of light emitted from correctly sized bands under ultraviolet light using a ChemiDoc EQ system and Quantity One software (Bio-Rad).
Immunoreactive proteins were detected using goat antirabbit polyclonal antibodies against phospho-proteins and total-proteins at a 1:1000 dilution and 10% SDS/PAGE gel. As a loading control, total proteins were used to normalize results from detection of proteins by western blotting. All antibodies were from Cell Signaling Technology. Multiple exposures of each western blot were performed to ensure linearity of chemiluminescent signals.
Statistical analyses
All quantitative data were subjected to least squares analysis of variance (ANOVA) using the general linear model procedures of the Statistical Analysis System (SAS Institute Inc., Cary, NC). Western blot data were corrected for differences in sample loading using total protein data as a covariate. All tests of significance were performed using the appropriate error terms according to the expectation of the mean squares for error. A P-value less than or equal to 0.05 was considered significant. Data are presented as least-square means with standard error (SE).
Results
Effects of day of the estrous cycle and pregnancy on expression of FGFR1 and FGFR2 in cells of the porcine endometrium
Based on the results of a previous study, the expression of FGF2 protein is known to be expressed primarily by uterine LE and GE during These experiments were performed in triplicate and normalized to control GAPDH expression. The asterisks indicate significant differences compared to day 9 estrous cycle ( * * * P < 0.001, * * P < 0.01, and * P < 0.05).
the peri-implantation period of pregnancy [16] . And, two of its receptors, FGFR1 (also known as FGFR1IIIc) and FGFR2 (also known as FGF2IIIc), are hormonally regulated in porcine endometria [21] . Therefore, this study focused on cell-specific and temporal expression of FGFR1 and FGFR2 in endometria of gilts during the estrous cycle and pregnancy. Steady-state levels of FGFR1 and FGFR2 mRNAs in the uteri were examined by quantitative RT-PCR analysis ( Figure 1 ). In cyclic gilts, steady-state levels of FGFR1 mRNA increased slightly with advancing day of the estrous cycle (P < 0.01).
As compared to the estrous cycle, the expression of FGFR1 mRNA was greater on day 9 (P < 0.01) and then increased (P < 0.001) from day 9 to 20 of pregnancy, and then decreased slightly to day 30 of pregnancy ( Figure 1A ). Expression of FGFR2 mRNA expression was greater on day 12 than day 9 of the estrous cycle, but less on day 15 of the estrous cycle than days 9 and 12; however, the expression of FGFR2 mRNA declined from day 9 to 12 of pregnancy, recovered on day 13, and then gradually increased on days 14 to 30 of pregnancy (P < 0.001 and P < 0.01) in the porcine endometrium ( Figure 1B ). Cell-specific localization of FGFR1 and FGFR2 mRNA in porcine endometrium during the estrous cycle and pregnancy was assessed using in situ hybridization analysis. As illustrated in Figure 2A , FGFR1 mRNA was weakly detected in uterine LE on days 9 and 12 of the estrous cycle, but increased slightly in uterine LE on day 15 of the estrous cycle. In addition, FGFR1 mRNA was also increased in uterine GE on day 15 as compared to uterine GE on days 9 and 12 of the estrous cycle. In pregnant gilts, FGFR1 mRNA was expressed moderately in uterine LE from day 9 to 14, but strongly expressed in uterine GE and LE from day 20 of pregnancy.
On the other hand, there was steady-state expression of FGFR2 in uterine GE and LE during both the estrous cycle and pregnancy (Figure 2B ). In addition, expression of FGFR2 mRNA was abundant in uterine GE and LE on day 14, 20, and 30 of pregnancy. These results indicated that the two main FGF2 receptors are expressed abundantly in uterine GE and LE during early pregnancy in pigs.
Effects of parity on expression of FGFR1 and FGFR2 in porcine endometria at the end of early pregnancy
Expression of FGFR1 and FGFR2 mRNAs in the porcine endometrium on day 30 of pregnancy was assessed for differences between primiparous (first) and multiparous (third and sixth) sows. As shown in Figure 3A , expression of FGFR1 mRNA decreased with increasing parity by 18% (P < 0.01) and 36% (P < 0.01) for third and sixth pregnancies, respectively. The expression of FGFR2 in the porcine endometrium also decreased 31% (P < 0.01) and 71% (P < 0.01) between the first and third and sixth pregnancies ( Figure 3B ). The decrease in expression of FGFR1 and FGFR2 mRNA in GE and LE was confirmed by in situ hybridization analyses ( Figure 3C and D).
Stimulatory effects of fibroblast growth factor 2 on proliferation and cell cycle regulation of porcine uterine luminal epithelial cells
Next, we investigated the effects of FGF2 on proliferation of pLE cells using recombinant FGF2. To demonstrate dose-response effects of FGF2 on cell proliferation, serum-starved pLE cells were incubated in culture medium containing 0, 0.1, 1, 10, 20, and 50 ng/mL FGF2 for 48 h prior to the assay. Proliferation of pLE cells increased in response to increasing concentrations of FGF2 from 0 to 20 ng/mL of FGF2. As illustrated in Figure 4A , proliferation of pLE cells increased 121%, 128% (P < 0.05), 161% (P < 0.01), and 189% (P < 0.01) in response to 0.1, 1, 10, and 20 ng/mL FGF2, respectively, compared with values for nontreated pLE cells. However, the highest concentration of FGF2 (50 ng/mL) did not significantly increase proliferation in pLE cells. Effects of FGF2 on proliferation of pLE cells were confirmed by evaluating effects on abundance of PCNA protein, an essential mediator of DNA replication, by immunofluorescence analysis (Figure 4B) . PCNA protein was abundant in nuclei of pLE cells in response to FGF2 compared to control pLE cells. To follow up on these observations, we analyzed the effects of FGF2 on progression of the cell cycle in pLE cells as illustrated in Figure 5 . We analyzed the cell cycle by quantitation of DNA content using PI and flow cytometry. Treatment of pLE cells with FGF2 (0-20 ng/mL) had minor effects on the G 1 and S phases of the cell cycle (Figure 5A and B) . However, 50 ng/mL FGF2 increased the G 2 /M phase compared to nontreated pLE cells, while G 1 and S phases were decreased. Consistent with these results, the distribution of Cyclin D1 in pLE cells, a promoter of cell growth, increased in response to 20 ng/mL FGF2, and it was abundant in nuclei of FGF2-treated pLE cells ( Figure 5C ). These results indicate that FGF2 induces proliferation of pLE cells through DNA replication and cell cycle progression. Fibroblast growth factor 2-mediated phosphatidylinositol 3-kinase/AKT and mitogen-activated protein kinase signal transduction cascades in porcine uterine luminal epithelial cells
To identify FGF2-activated signal transduction in pLE cells, we determined the state of phosphorylation of signaling molecules associated with PI3K/AKT and MAPK pathways mainly associated with proliferation and growth of cells. As illustrated in Figure 6A -C, the phosphorylation of AKT, P70S6K, and S6 proteins increased in response to 20 ng/mL FGF2 at 15 min, and then decreased to basal levels by 120 min after FGF2 treatment. For MAPKs, phosphorylated ERK1/2 protein increased 1.2-fold within 5 min in response to FGF2, and this phosphorylated status gradually decreased to 120 min (Figure 6D) . The phosphorylation of c-Jun N-terminal kinase (JNK) increased gradually between 0 and 60 min (1.1-1.5-fold compared to nontreated pLE cells; Figure 6E ). Moreover, the phosphorylation of P38 protein increased significantly within 5 min, and the effect was maintained to 120 min ( Figure 6F ). Furthermore, a downstream signaling molecule of MAPK signaling, P90RSK, was increased approximately 1.8-fold within 5 min, and this phosphorylated status decreased slightly to 15 min and was then maintained to 120 min ( Figure 6G ). The next step was to preincubate pLE cells with pharmacological inhibitors of cell signaling including Wortmannin (a PI3K inhibitor, 1 μM), U0126 (an ERK1/2 MAPK inhibitor, 20 μM), SP600125 (a JNK inhibitor, 20 μM), and SB203580 (a P38 MAPK inhibitor, 20 μM) to confirm FGF2-regulated cell signaling pathways ( Figure 7) . Phosphorylation of AKT, P70S6K, and S6 proteins was inhibited most by Wortmannin (P < 0.01 and P < 0.05), but also by U0126 (P < 0.05) in pLE cells ( Figure 7A-C) . However, phosphorylation of those proteins increased in response to SP600126, and there was no significant effect of SB203580 on p-AKT and p-70S6K. Also, increases in phosphorylation of MAPKs (ERK1/2, JNK, and P38) were inhibited only by U0126 (P < 0.01; Figure 7D-F) . Moreover, the P90RSK protein was inhibited by U0126 and SB203580, whereas its expression increased in response to SP600125 ( Figure 7G ). In support of those results, p-AKT and p-ERK1/2 were abundant in the cytoplasm of pLE cells, but p-AKT was at low basal levels in nontreated pLE cells (Figure 8 ). In addition, the abundances of p-AKT and p-ERK1/2 proteins were completely suppressed by Wortmannin and U01226, respectively. These results indicate that FGF2 activation of PI3K/AKT and MAPKs signaling proteins is required for FGF2-mediated effects on pLE cells. Fibroblast growth factor 2 regulates proliferation and migration of porcine uterine luminal epithelial cells: effects of pharmacological inhibitors of phosphatidylinositol 3-kinase/AKT and mitogen-activated protein kinase cell signaling pathways
To confirm cell signaling pathways whereby FGF2 mediates biological effects on pLE cells, cell proliferation and migration assay were conducted as illustrated in Figure 9 . Although FGF2 increased proliferation of pLE cells approximately 149% (P < 0.01), the combinations of FGF2 and Wortmannin, U0126, SP600125, or SB203580 reduced FGF2-induced proliferation of pLE cells by 67.8%, 88.6%, 84%, and 40%, respectively (P < 0.05) as compared to pLE cells treated with only FGF2 ( Figure 9A ). Further, FGF2-independent proliferation of pLE cells was reduced by each of the pharmacological inhibitors as one might expect. Stimulatory effects of FGF2 on migration of pLE cells were also determined ( Figure 9B and C). Fibroblast growth factor 2 increased migration of pLE cells approximately 219% (P < 0.01), and this effect was inhibited significantly by Wortmannin (62%), U0126 (73%), SP600125 (60%), and SB203580 (34%), respectively. These results confirmed that FGF2 activates proliferation and migration of pLE cells of pigs through the PI3K/AKT and MAPKs signal transduction cascades.
FGFR inhibitor regulates fibroblast growth factor 2-induced proliferation and phosphatidylinositol 3-kinase and mitogen-activated protein kinase signal transduction in porcine uterine luminal epithelial cells
To determine inhibitory effects of FGFR, cell proliferation assays and western blot analyses were performed using a FGFR tyrosine kinase inhibitor, BGJ398 (Figure 10 ). Induction of proliferation of pLE cells by FGF2 (20 ng/mL; 170%, P < 0.01) was inhibited by approximately 52% (P < 0.05) by BGJ398 (5 μM) as compared to the effects of FGF2 alone ( Figure 10A ). In addition, BGJ398 reduced proliferation of pLE cells approximately 44% (P < 0.05) compared with nontreated pLE cells. Moreover, FGF2-induced phosphorylation of AKT, P70S6K, S6, ERK1/2, JNK, P38, and P90RSK in pLE cells was reduced by BGJ398 ( Figure 10B-H) . Although, BGJ398 alone decreased phosphor-AKT, P70S6K, S6, and P90RSK in pLE cells, it did not alter phosphor-JNK protein, and it increased phosphor-ERK1/2 and P38 proteins as compared with nontreated pLE cells. These results indicate that the FGFR regulates FGF2-induced proliferation and phosphorylation of protein kinases belonging to the PI3K and MAPK signal transduction pathways in pLE cells.
Discussion
Results of this study revealed cell-specific and temporal patterns of expression of FGF2 receptors (FGFR1IIIc and FGFR2IIIc isoforms) in the porcine uterus during the estrous cycle and early pregnancy.
Expression of both of those receptors was maintained until day 30 of pregnancy in the uterine epithelia of gilts ( Figures 1 and 2) ; however, their expression decreased with increasing parity in sows (Figure 3) . Moreover, FGF2-induced proliferation and migration of pLE cells was mediated via PI3K/AKT and MAPK cell signaling ( Figure 11 ). These findings support our hypothesis that FGF2 and its receptors are essential for successful implantation and suggest that supplementation of FGF2 during early pregnancy may enhance proliferation and migration of pLE cells to increase uterine receptivity to implantation by porcine conceptuses during the peri-implantation period of pregnancy.
A major aim of domestic animal production is to enhance reproductive efficiency. Litter size is the most important economic trait for enhancing reproductive performance. In pigs, litter size is influenced by the rates of ovulation, fertilization, embryonic survival, implantation, placentation, and parity of the sow. Although increased numbers of oocytes is required to improve litter size, ovulation rate is negatively related to embryonic survival [23] . Also, the fertilization rate of oocytes in pigs is greater than 95%. However, embryonic death losses of 25%-40% during the peri-implantation period of pregnancy are a major obstacle to achieving high litter size [2, 24] . This results from failure of blastocysts to transition from spherical to tubular and filamentous forms in preparation for implantation and placentation at the maternal-fetal interface. Further, establishment and maintenance of pregnancy by porcine conceptus requires development of the appropriate uterine microenvironment through secretion or transport of molecules that comprise histotroph that includes hormones, nutrients, growth factors, and cytokines [3] . Thus, based on these findings, it is likely that the lack of histotroph would impair placentation and result in reduced litter size due to deficits in angiogenesis. Moreover, litter sizes decreases after the fifth parities in pigs due to reduced uterine receptivity to implantation and placentation [25] [26] [27] . We determined expression of MUC1 mRNA in the endometrium in response to parity (Supplemental Figure S1 ) and found it to be downregulated in uteri of sows at third parity compared with primiparity, but upregulated in sixth parity as compared with third parity sows. As a surface extracellular matrix glycoprotein on uterine epithelial cells, MUC1 inhibits implantation and must be downregulated to allow for successful implantation [28, 29] . Our results indicate changes in expression of MUC1 in response to parity that may reflect differences in FGF2 transactivation of FGFR1 and FGFR2 to affect uterine receptivity, as well as among sow variations in litter size. Collectively, results of this study suggest that expression of FGF2 receptors is closely associated with the periods of implantation and placentation and that FGF2 may be a novel genetic marker associated with litter size in pigs. FGF family members have important roles during implantation and pregnancy in domestic animals, as well as women and rodents. For instance, FGF2 is expressed predominantly by syncytiotrophoblast and cytotrophoblast cells in human placenta during the first trimester of pregnancy [30] . The abundance of FGF2 increases in the uterine luminal epithelial cells and decidual cells throughout implantation of blastocysts in rats [31] . Also, increased expression of FGF1 and FGF2 as well as FGFR1 and FGFR2 enhances formation and development of porcine umbilical cord during pregnancy [32] . In addition, FGF7 is abundant during the peri-implantation period of pregnancy in pigs and exerts autocrine and paracrine effects to supports adhesion of porcine conceptus trophectoderm to uterine LE in pigs and formation of a true epitheliochorial type of placenta [33] . In sheep, expression of FGF10 by uterine stromal cells increases in response to progesterone during the luteal phase of the estrous cycle and the peri-implantation period of pregnancy. Acting as a progestamedin, FGF10 induces successful placentation through interactions between FGF10 in chorioallantoic mesenchyme and its receptor (FGFR2IIIb) in adjacent ovine trophectoderm [34] . And, in sheep, both progestamedins and IFNT influence uterine receptivity for implantation and hormonal regulation of gene expression via the MAPK and PI3K/AKT signaling pathways [35, 36] . In spite Figure 11 . Schematic representation of FGF2-mediated PI3K/AKT, ERK1/2 MAPK, and P38 MAPK signaling pathways in pLE cells during pregnancy. Following FGF2 binding and receptor dimerization, the kinase domains transphosphorylate each other leading to activation of PI3K-AKT and RAS-MAPKs signal transduction pathways in pLE cells. Specifically, FGF2 induces phosphorylation of PI3K downstream signaling proteins (AKT, P70S6K, and S6) and RAS downstream signaling proteins (ERK1/2, P38, and JNK). The ERK1/2 and P38 MAPK also regulate AKT signal transduction and cross-talk with JNK signaling. Also, P90RSK is downregulated by ERK1/2 and P38 in FGF2-treated pLE cells. Then, nuclear translocation of signaling molecules occurs and those interact with transcription factors for growth, differentiation, survival, and development of porcine endometrial cells during the peri-implantation period of pregnancy.
of abundant expression of FGF2 by uterine epithelial and stroma cells during the estrous cycle and the peri-implantation period of pregnancy [16] , intracellular signaling pathways mediated by FGF2 have not been elucidated in the porcine endometrium. In this study, we demonstrated that FGF2 increases proliferation and migration of pLE cells. The effects of FGF2 on proliferation of pLE cells were to increase DNA replication as indicated by abundant expression of PCNA. In addition, the G 1 to S phase of the cell cycle increased slightly in response to FGF2 in a dose-dependent manner. However, the increase in the G 1 and S phases in response to 20 ng FGF2 decreased at 50 ng FGF2, whereas the G 2 /M phase increased in response to 50 ng FGF2. These results may explain the reduction in proliferation of pLE cells treated with 50 ng FGF2. The G 2 /M phase arrest occurs due to downregulation of proliferation and induction of apoptosis of cells [37] . These results indicated that a high concentration of FGF2, that is, more than 50 ng, have cytotoxic effects on pLE cells. But, further studies are necessary to identify specific regulatory mechanisms affecting the cell cycle in pLE cells treated with different concentrations of FGF2. Taken together, these results indicate that uterine FGF2 has significant effects on uterine luminal epithelial cells for appropriate uterine receptivity to implantation and placentation.
FGF2 regulates multiple signal transduction pathways leading to development, growth, proliferation, and differentiation of cells [38] . For self-renewal of embryonic stem cells (ESC), FGF2 activates the Ras-ERK1/2 pathway regulating FGF2-mediated genes such as inhibin βB, gremlin 1, and FGF7 in mouse embryonic fibroblasts [39] . In human embryonic stem cells (hESC), FGF2 acts cooperatively with Activin/Nodal signaling for long-term maintenance of pluripotency [40] . Also, FGF2 supports pluripotency in hESC through transforming growth factor β signaling pathways [41] . Endometrial-derived FGF2 significantly improves implantation rate by induction of trophoblast outgrowth through its cognate receptors, FGFR1 and FGFR2, as a paracrine regulator in mice [14] . In addition, endometrial epithelial cell-derived FGF2 stimulates production of IFNT by bovine trophoblast cells through regulation of protein kinase C subfamily genes (PRKCD genes) [42] . Moreover, uterine-and conceptus-derived FGF2 and FGF10 stimulate MAPK-dependent pathways that increase migration of ovine trophectoderm cells during the peri-implantation of pregnancy [43] . Because intracellular events in pLE cells affected by FGF2 were not known, we investigated signal transduction pathways mediated by FGF2 in pLE cells. Fibroblast growth factor 2 increased phosphorylation of PI3K/AKT and MAPK (EKR1/2, JNK, and P38) signaling molecules in pLE cells in time-dependent manner and inhibition of ERK1/2 MAPK signaling decreased FGF2-induced phosphorylation of AKT, P70S6K, S6, JNK, P38, and P90RSK as well as phosphor-EKR1/2. Furthermore, selective inhibition of those cell signaling pathways prevented FGF2 from increasing proliferation and migration of pLE cells. We next analyzed effects of BGJ398, a potent and selective FGFR inhibitor for FGFR1, 2, and 3, on proliferation and signal transduction in pLE cells treated with FGF2. BGJ398 has therapeutic potential to regulate growth of tumors in endometrial cancer [44] and bladder cancer [45] xenograft models. It suppresses FGF2-induced angiogenesis in a dose-dependent manner by regulating vascular endothelial growth factor receptor 2, FGFRs, and platelet-derived growth factor receptor beta (PDGFRβ). In this study, BGJ398 reduced FGF2-stimulated proliferation of pLE cells and downregulated phosphor-proteins within the PI3K and MAPK signaling pathways. These results indicate that FGF2 transactivates intracellular signaling via FGFRs, PI3K, and MAPK pathways in pLE cells. Based on previous studies, several conceptus-and endometrialderived molecules in histotroph, including EGF, IGF, VEGF, and PDGF activate PI3K and ERK1/2 MAPK signaling pathways to induce elongation and migration of porcine trophectoderm cells to enhance implantation [6] [7] [8] 46] . Thus, PI3K/AKT and MAPK cell signaling or their cross-talk plays important roles in facilitating implantation of mammalian conceptuses [47] [48] [49] [50] . Also, downregulation of MUC1 mRNA by 20 ng FGF2 showed that FGF2 may improve uterine receptivity by removal of that surface glycoprotein from uterine luminal epithelial cells to allow for implantation in pigs (Supplemental Figure S1 ). Our results indicate that stimulatory effects of FGF2 on cell proliferation and migration are also regulated by PI3K/AKT and MAPKs signal transduction cascades.
Collectively, results of this study indicate that FGFR1 and FGFR2 are high-affinity receptors for FGF2, which may then enhance uterine receptivity to implantation and placentation. In addition, interaction between FGF2 and its receptors in uterine LE results in their proliferation and migration during early pregnancy in pigs through G1/S-phase progression. The proliferation and migration of pLE cells in response to FGF2 is mediated by PI3K/AKT and MAPK signal transduction pathways that is likely critical to maternal-conceptus interactions during early pregnancy in pigs.
Supplementary data
Supplementary data are available at BIOLRE online. Figure S1 . Effects of parity on expression of MUC1 mRNA in pLE cells in response to FGF2. (A) Relative expression of MUC1 mRNA in endometria (day 30 of pregnancy) of sows of differing parities was analyzed by quantitative RT-PCR. (B) Comparative expression of MUC1 mRNA between nontreated pLE cells and FGF2 (20 ng/mL)-treated pLE cells was analyzed by quantitative RT-PCR. These experiments were performed in triplicate and normalized to control GAPDH expression. The asterisks indicate significant differences compared to primiparous sows ( * * P < 0.01 and * P < 0.05) and nontreated pLE cells ( * * P < 0.0), respectively.
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